Trial intelligence / Profile preview

NEURAPAS balance for mild depressive episodes with nervous restlessness in adolescents

2012-004627-20Phase 3Terminated

Sponsor
Pascoe
Start
Feb 2013
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of Neurapas balance in major depressive episode (MDE) (3 arms), sponsored by Pascoe. Started Feb 2013; status: terminated.

02

Drugs

Neurapas balance
03

Conditions

major depressive episode (MDE)

Beyond the preview

Go deeper on 2012-004627-20.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-004627-20.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call